Overview

Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of fesoterodine in comparison to placebo for overactive bladder.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Fesoterodine